Synchronicity Pharma

Developing circadian clock gene modulating therapeutics for treating multiple diseases

placeSan Francisco, California, United States calendar_todayFounded 2008 groups12 employees language synchronicitypharma.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%
Coming soon